Printer Friendly

Glaxo SmithKline to close plant.

Drug maker GlaxoSmithKline PLC said it will close its plant in Cidra, opened in 196, due to declining sales of drugs including the diabetes treatment Avandia, reports AP (Oct. 24, 2007). The company will transfer production of Avandia and the related drug Avandamet to other facilities and reduce its work force in Cidra from 900 to about 250 by the end of this year, said Stef Mendell, a Raleigh, N.C.-based spokeswoman for the London-based company. Avandia sales were hurt by a New England Journal of Medicine article in May that said it raised the risk of heart attack by 43%. The FDA ruled in July that Avandia could remain on the market.
COPYRIGHT 2007 Caribbean Update, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:PUERTO RICO
Publication:Caribbean Update
Date:Dec 1, 2007
Previous Article:Plant closures, cutbacks.
Next Article:Bristol-Myers Squibb plant to close.

Related Articles
Johnson & Johnson expansion.
Pfizer to close Arecibo Plant.
Schering-Plough to close plant.
Pharmaceutical plant to close.
Bristol-Myers Squibb plant to close.
Pfizer to cut 40 jobs.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters